Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,384 | -1,629 | -1,225 | -1,017 | -1,148 |
| Depreciation Amortization | 61 | 43 | 23 | 2 | 2 |
| Accounts receivable | 98 | -73 | -52 | -26 | N/A |
| Other Working Capital | -391 | 218 | -52 | -141 | 166 |
| Other Operating Activity | 23,027 | 965 | 882 | 915 | 575 |
| Operating Cash Flow | $-1,589 | $-475 | $-425 | $-266 | $-405 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -1 | -1 | 0 |
| Investing Cash Flow | $-1 | $-1 | $-1 | $-1 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200 | 200 | 200 | 100 | N/A |
| Common Stock Issued | 18,649 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -71 | -53 | -35 | 0 |
| Financing Cash Flow | $18,849 | $129 | $147 | $65 | $0 |
| Exchange Rate Effect | -5 | -6 | -3 | -8 | 62 |
| Beginning Cash Position | 391 | 391 | 391 | 391 | 734 |
| End Cash Position | 17,645 | 38 | 111 | 181 | 391 |
| Net Cash Flow | $17,253 | $-353 | $-281 | $-210 | $-343 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,589 | -475 | -425 | -266 | -405 |
| Capital Expenditure | -1 | -1 | -1 | -1 | N/A |
| Free Cash Flow | -1,590 | -476 | -425 | -267 | -405 |